Discontinued — last reported Q3 '23
Non-Current Assets
Equity Method Investments
ResMed Equity Method Investments increased by 21.1% to $78.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from $65.38M to $78.47M. Over 4 years (FY 2021 to FY 2025), Equity Method Investments shows an upward trend with a 29.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ3 2023
How to read this metric
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
Detailed definition
These are investments in entities where the company exercises significant influence but does not have full control. The...
Peer comparison
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
Metric ID:
equity_method_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.00M | $31.16M | $35.18M | $38.18M | $39.29M | $43.58M | $65.70M | $70.64M | $68.75M | $69.68M | $74.99M | $77.38M | $73.74M | $65.78M | $66.46M | $65.38M | $63.64M | $64.53M | $64.78M | $78.47M |
| QoQ Change | — | +35.5% | +12.9% | +8.5% | +2.9% | +10.9% | +50.7% | +7.5% | -2.7% | +1.4% | +7.6% | +3.2% | -4.7% | -10.8% | +1.0% | -1.6% | -2.7% | +1.4% | +0.4% | +21.1% |
| YoY Change | — | — | — | — | +70.8% | +39.9% | +86.7% | +85.0% | +75.0% | +59.9% | +14.1% | +9.5% | +7.3% | -5.6% | -11.4% | -15.5% | -13.7% | -1.9% | -2.5% | +20.0% |
Range$23.00M – $78.47M
CAGR+29.5%
Avg YoY Growth+26.1%
Median YoY Growth+11.8%
Current Streak3 quarters growth
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is ResMed's equity method investments?
- ResMed (RMD) reported equity method investments of $78.47M in Q1 2026.
- How has ResMed's equity method investments changed year-over-year?
- ResMed's equity method investments increased by 20.0% year-over-year, from $65.38M to $78.47M.
- What is the long-term trend for ResMed's equity method investments?
- Over 4 years (2021 to 2025), ResMed's equity method investments has grown at a 29.0% compound annual growth rate (CAGR), from $23.00M to $63.64M.
- What does equity method investments mean?
- The value of investments in other companies where the firm has significant influence but not total control.